Page last updated: 2024-10-27

gabexate and Cancer of Kidney

gabexate has been researched along with Cancer of Kidney in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomita, N1
Kanamori, H1
Fujita, H1
Maruta, A1
Naitoh, A1
Nakamura, S1
Ota, Y1
Nozue, N1
Kihara, M1
Ishigatsubo, Y1
Mikata, N1
Imao, S1
Tanaka, Y1
Horiuchi, D1
Matsumoto, G1
Hasegawa, K1

Other Studies

2 other studies available for gabexate and Cancer of Kidney

ArticleYear
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
    Anti-cancer drugs, 2001, Volume: 12, Issue:8

    Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic

2001
[A case of renal cancer complicated with acute hypercalcemia and acute pancreatitis].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:11

    Topics: Acute Disease; Calcitonin; Emergencies; Gabexate; Guanidines; Humans; Hypercalcemia; Kidney Neoplasm

1989